Trust Among Most Top Gainer Stocks in Nasdaq Pre-Market (SGYP, CECO, AMRN, HOTT)

Los Angelas, CA -- (SBWIRE) -- 11/16/2012 -- Shares of Synergy Pharmaceu (NASDAQ:SGYP) are trading at $4.21 and is -2.94% from its 50-day Moving Average price of $4.3376 and -7.29% from its 200-day Moving Average price of $4.541. The average trading volume is 269366 shares and its market capitalization is $278.3M. Synergy Pharmaceuticals (SGYP): Investors have monitored shares of Synergy Pharmaceuticals over the past few weeks as they plunged back towards the three dollar mark following months of hovering near five. Considering the upcoming trial catalysts, however, it was also noted during the slide that SGYP could turn into a pretty quick rebound play. Following an earnings report that was more about providing an update for Plecanatide than it was about the numbers, shares spiked by twenty percent during Wednesday's trading session and indicated positive investor sentiment leading into the expected late-year 2012/early-year 2013 catalysts.

Should Investor Invest Money On SGYP At This Level : Click Here To Know More

Shares of Career Education (NASDAQ:CECO) are trading at $2.72 and is -27.33% from its 50-day Moving Average price of $3.7429 and -44.99% from its 200-day Moving Average price of $4.9442. The average trading volume is 725864 shares and its market capitalization is $182.5M. Cisco Systems (NasdaqNM:CECO) Cisco was another earnings winner on Wednesday as shares jumped on heavy volume after the company reported on Tuesday evening some nice increases in profits and revenues for the most recently-completed quarter. The company also provided more upbeat guidance than expected moving forward, compelling at least one analyst to upgrade its opinion on the stock. Cisco's report provided a modest boost for others in the tech sector, too, and joined in what could be viewed as one of the better weeks of the current earnings quarter.

Is CECO A Solid Investment At These Levels : Find Out Here

Amarin Corporatio (NASDAQ:AMRN) reported EPS of -1.074. For the Current Fiscal year, the company is expected to report EPS of -1.56. For the Next Quarter and Next Year, the company is expected to report EPS of -0.18 and -0.07 respectively. At Current Market Price, AMRN is in distance of -2.93% from its 50-day Moving Average price of $11.5791 and -10.16% from its 200-day Moving Average price of $12.5113. Amarin Corporation plc (NASDAQ:AMRN): Calcalist financial daily stated that Teva (NYSE:TEVA) is the top candidate to purchase Amarin, according to Reuters. The publication has also stated that AstraZeneca (AZZN) is also considering purchasing the Irish biopharmaceutical company. Amarin’s market value on Nasdaq is $1.6 billion.

To Know More The Prospective Result of AMRN Free Sign Up Here

Shares of Hot Topic, Inc. (NASDAQ:HOTT) are trading at $9.05 and is +3.31% from its 50-day Moving Average price of $8.76 and -5.82% from its 200-day Moving Average price of $9.6091. The average trading volume is 546910 shares and its market capitalization is $382.7M. Piper Jaffray upgraded shares of Hot Topic Inc (HOTT) from a neutral rating to an overweight rating. Piper Jaffray now has a $11.00 price target on the stock. They wrote, "We are upgrading shares of HOTT from Neutral to Overweight based on attractive valuation, increased confidence in estimates, and a shift in our investment rationale from recovery to growth. On its Q3 report, the company detailed accelerated square footage growth plans for 2013, which was the catalyst we were seeking to revisit our thesis. In addition, margin initiatives are taking hold at a faster pace than initially modeled, lending to further profitability expansion. We expect a series of Street interactions over the next few months to add to visibility and confidence in underlying operating stability and growth."

Receive The Update Via Email About HOTT: Free Sign Up Here

Disclaimer
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to loose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com